RQA membership is a great way to connect with your QA colleagues.
More information
Join the community - networking, discussion and more. Open to all.
More information
Could you write an interesting article for the RQA community?
More information18th November 2026
The MHRA has published new guidance on how it will treat UK clinical trial applications that use non-clinical safety data generated outside the OECD Mutual Acceptance of Data (MAD) system. It is running a free-to-register online webinar to explain what this means in practice.
If you work in GLP, this goes straight to the question of how your study data will be judged when it comes from a test facility outside the MAD framework.
The session takes place online on Tuesday 1 December 2026, 12:30 to 14:00 GMT. MHRA experts will walk through the agency's risk-proportionate approach, which rests on three areas: targeted inspection and compliance intelligence, enhanced non-clinical assessment, and greater transparency on how clinical data is used in regulatory decisions. They will also cover when the approach is likely to apply and why early engagement with the MHRA matters. There is time for questions at the end.
The webinar is aimed at sponsors and developers. GLP QA professionals, study directors and anyone who audits or relies on non-clinical data from overseas facilities should also find it useful.
Register here: https://www.eventbrite.co.uk/e/using-non-oecd-mad-data-in-uk-clinical-trial-applications-tickets-2004703331630